NO20041607L - Doseringsregime og farmasoytisk preparat for nodprevensjon - Google Patents

Doseringsregime og farmasoytisk preparat for nodprevensjon

Info

Publication number
NO20041607L
NO20041607L NO20041607A NO20041607A NO20041607L NO 20041607 L NO20041607 L NO 20041607L NO 20041607 A NO20041607 A NO 20041607A NO 20041607 A NO20041607 A NO 20041607A NO 20041607 L NO20041607 L NO 20041607L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
dosage regimen
node
prevention
node prevention
Prior art date
Application number
NO20041607A
Other languages
English (en)
Other versions
NO333984B1 (no
Inventor
Paul F A Van Look
Illesne Bologh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20041607L publication Critical patent/NO20041607L/no
Publication of NO333984B1 publication Critical patent/NO333984B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20041607A 2001-11-27 2004-04-20 Farmasøytisk preparat for nødprevensjon og anvendelse derav. NO333984B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number Publication Date
NO20041607L true NO20041607L (no) 2004-04-20
NO333984B1 NO333984B1 (no) 2013-11-04

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041607A NO333984B1 (no) 2001-11-27 2004-04-20 Farmasøytisk preparat for nødprevensjon og anvendelse derav.

Country Status (33)

Country Link
US (1) US20050288264A2 (no)
EP (1) EP1448207B1 (no)
JP (1) JP2005516904A (no)
KR (1) KR100908161B1 (no)
CN (1) CN1551774A (no)
AP (1) AP1849A (no)
AT (1) ATE293978T1 (no)
AU (1) AU2002347401A1 (no)
BR (1) BR0210595A (no)
CA (1) CA2450359C (no)
DE (1) DE60203929T2 (no)
DK (1) DK1448207T3 (no)
EA (1) EA006545B1 (no)
EC (1) ECSP045171A (no)
ES (1) ES2239727T3 (no)
GE (1) GEP20063882B (no)
HR (1) HRP20040584B1 (no)
HU (1) HU227198B1 (no)
IL (1) IL159394A0 (no)
IS (1) IS2691B (no)
MA (1) MA27076A1 (no)
MX (1) MXPA04005104A (no)
NO (1) NO333984B1 (no)
NZ (1) NZ530056A (no)
OA (1) OA12730A (no)
PL (1) PL206010B1 (no)
PT (1) PT1448207E (no)
RS (1) RS50768B (no)
SI (1) SI1448207T1 (no)
TN (1) TNSN04048A1 (no)
UA (1) UA79942C2 (no)
WO (1) WO2003045397A1 (no)
ZA (1) ZA200404114B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465907C2 (ru) * 2006-12-20 2012-11-10 Тева Вимен'С Хелс, Инк. Распадающиеся в полости рта твердые дозированные формы, содержащие прогестин, и способы получения и применение указанных дозированных форм
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) * 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
WO2010119029A1 (en) 2009-04-14 2010-10-21 Laboratoire Hra-Pharma Method for on-demand contraception
CN102458386B (zh) 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
RS54880B1 (sr) 2011-06-01 2016-10-31 Estetra Sprl Postupak proizvodnje intermedijarnih proizvoda estetrola
ME02585B (me) 2011-06-01 2017-06-20 Estetra Sprl Postupak proizvodnje intermedijara estetrola
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
CA2843951C (en) * 2011-08-11 2019-08-06 Wout WOUTERS Use of estetrol as emergency contraceptive
SG11201503275RA (en) 2012-11-22 2015-06-29 Bayer Pharma AG Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
CN105451737B (zh) 2013-05-23 2018-04-10 拜耳医药股份有限公司 药物组合物及其用途以及所述药物组合物用于按需避孕的施用方法
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
TNSN04048A1 (en) 2006-06-01
KR100908161B1 (ko) 2009-07-16
EA200400731A1 (ru) 2004-12-30
WO2003045397A1 (en) 2003-06-05
CA2450359C (en) 2011-05-10
JP2005516904A (ja) 2005-06-09
ECSP045171A (es) 2004-08-27
AP2004003046A0 (en) 2004-06-30
ATE293978T1 (de) 2005-05-15
EP1448207B1 (en) 2005-04-27
ZA200404114B (en) 2005-10-26
HU227198B1 (en) 2010-10-28
MA27076A1 (fr) 2004-12-20
EP1448207A1 (en) 2004-08-25
NZ530056A (en) 2005-02-25
PL369520A1 (en) 2005-04-18
BR0210595A (pt) 2004-06-08
RS4204A (sr) 2007-02-05
OA12730A (fr) 2006-06-28
DK1448207T3 (da) 2005-06-27
SI1448207T1 (en) 2005-10-31
PL206010B1 (pl) 2010-06-30
UA79942C2 (en) 2007-08-10
NO333984B1 (no) 2013-11-04
US20050288264A2 (en) 2005-12-29
HUP0105173D0 (en) 2002-02-28
EA006545B1 (ru) 2006-02-24
MXPA04005104A (es) 2004-08-19
HRP20040584A2 (en) 2005-02-28
KR20040066088A (ko) 2004-07-23
DE60203929D1 (de) 2005-06-02
IS7065A (is) 2003-12-05
IL159394A0 (en) 2004-06-01
HRP20040584B1 (en) 2012-11-30
RS50768B (sr) 2010-08-31
AU2002347401A1 (en) 2003-06-10
DE60203929T2 (de) 2006-01-19
AP1849A (en) 2008-05-23
HUP0105173A2 (hu) 2003-08-28
GEP20063882B (en) 2006-07-25
US20050032755A1 (en) 2005-02-10
HUP0105173A3 (en) 2004-03-29
CN1551774A (zh) 2004-12-01
CA2450359A1 (en) 2003-06-05
IS2691B (is) 2010-10-15
PT1448207E (pt) 2005-08-31
ES2239727T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
NO20033143L (no) Farmasoytisk preparat
NO20030418D0 (no) Nytt farmasöytisk preparat
PT1390063E (pt) Forma de dosagem farmaceutica de mesilato de nelfinavir amorfo
NO20033556L (no) Farmasöytiske formuleringer
NO20033785D0 (no) Farmasöytisk formulering
ITTO20010008A0 (it) Formulazione farmaceutica
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
NO20043904L (no) Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
NO20032517D0 (no) Farmasöytisk preparat inneholdende amlodipinmaleat
NO20035627D0 (no) Farmasöytisk formulering
NO20033042D0 (no) Cyklodekstrin-inneholdende farmasöytisk preparat
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
IS7065A (is) Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
NO20025805L (no) Farmasöytisk preparat
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DK200300348U4 (da) Fast farmaceutisk dosisform omfattende amlodipinmaleat
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20033162D0 (no) Farmasoytisk tablett omfattende paroksetinmesylat
NO20021036L (no) Farmasöytisk preparat
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20041236L (no) Farmasoytisk formulering

Legal Events

Date Code Title Description
MK1K Patent expired